about
S-adenosyl-L-methionine for people with alcoholic liver diseaseGlucocorticosteroids for people with alcoholic hepatitisHoming in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosisPotential effects of curcumin on peroxisome proliferator-activated receptor-γ in vitro and in vivoAtherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C VirusUltrasound imaging of the liver and bile ducts - expectations of a clinicianAcupuncture in treating hepatic fibrosis: a review with recommendation for future studiesHypoxia and fibrosis in chronic kidney disease: crossing at pericytesCellular and molecular mechanisms in the pathogenesis of liver fibrosis: An updatePDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancerEfficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settingsPyrroloquinoline-quinone suppresses liver fibrogenesis in miceVirologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes.Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cellsLiver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Short-term effects of splenectomy on serum fibrosis indexes in liver cirrhosis patients.Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations.Recent advances in molecular magnetic resonance imaging of liver fibrosisEvolving therapies for liver fibrosis.Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells via SKP2/P27 signaling pathway.Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinAnalysis of effect of antiviral therapy on regression of liver fibrosis in patient with HCV infectionPathobiology of liver fibrosis: a translational success storyMultiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography.Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis.Up-regulation of RACK1 by TGF-β1 promotes hepatic fibrosis in miceAngiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.In vitro reversion of activated primary human hepatic stellate cellsInsulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats.Soluble Egg Antigens of Schistosoma japonicum Induce Senescence of Activated Hepatic Stellate Cells by Activation of the FoxO3a/SKP2/P27 Pathway.Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy.Hepatic stellate cells in liver development, regeneration, and cancer.Sustained virological response: a milestone in the treatment of chronic hepatitis C.Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway.Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapiesPreparing the ground for tissue regeneration: from mechanism to therapy.
P2860
Q24188235-041CCABD-2CEE-45DE-B81A-23467AAE39F5Q26471655-29D9FFA5-2A04-429C-9AF1-2FFDCBA65C1BQ26742049-D112595D-B84E-4994-9B8B-763B4C08B867Q26750543-D819A5C4-2FC5-4DD6-95B2-D9C27CF86D53Q26765245-DAD59395-9354-4D4F-AA63-16F7529875DEQ26775551-45494707-3564-4773-8F05-2A9738644C67Q26830737-1546F982-F9D4-4EE8-BE0A-7F0AEB5DFDC3Q26860894-AD2BD242-ED99-4B73-97DD-B88288D33178Q27027703-6DD055F8-A263-487E-845C-3363B65D8526Q28085644-A70C9AE4-86CC-4E91-A942-4ABE5BA47F08Q28540372-F89C2D93-570A-4DBB-B9E9-37BCF0AD7254Q28545190-A38801A1-281F-4383-93A1-02C494570711Q30250322-AB707494-FA27-491A-8BCC-C076C53F03F0Q30369750-1695CDB0-26D6-4A8B-BC4F-F6E34FA673FCQ30374500-77982416-4A60-4A48-9F46-ECCF10B01DDCQ30392792-C84388EF-7041-4F10-9399-5A99DEE0D487Q30395051-D9E5E437-8479-48BB-A7F8-0D545CB392ACQ30414378-A6B5BE6D-4C88-4D04-92D5-221069962942Q30539166-45BB1449-9680-461B-BEEE-78D9AE303D0DQ33591426-3460F965-3BE0-4C35-8FB6-1876FBE655BBQ33670909-33A5D707-3F04-437C-8E4F-9D3F7ACD61BDQ33861095-C8D4D7B3-2B8E-4C98-8542-9131AAE866F2Q33877800-7C6E509B-8AA1-44EB-B318-7F4957E4A7E0Q34035767-9B7520F5-9628-45F3-A90A-E36916BFF8AAQ34462733-C2D3B5E5-B328-429C-BFDB-551A835A32D1Q34476310-20A8914D-54B5-4369-8C62-489B11CB6B20Q34532528-900ECDBC-1F92-4610-A0EE-32494B4CE2BCQ34542461-025CBC7E-456E-4A31-9E18-E17E59241464Q34653295-45FF1ED5-3724-4ABB-A13E-42BA48B12B5BQ35025282-CC6C58A9-480B-4947-BC0A-0AC8F8264095Q35923294-9BBCD09B-83C5-458B-9B94-09EB9AB93F70Q36141134-523D62ED-801D-4048-9C09-8006F5D692D5Q36236493-EC2C5F6A-B1FE-4E49-9811-0B25F6C72784Q36708245-82B7C5BE-0532-47FB-86D2-80FA9C3E7BE4Q36793474-0FDFDA61-F75D-412E-A8A3-74B736D37C0CQ36841325-34F4BB2B-8697-4642-A552-59B60B20A8ACQ37151544-883E0245-584A-4ED0-8CE7-819471E56197Q37701235-0F41B5A9-B017-48A0-91F1-E5EB4331EDCBQ38073028-A5D480F8-D02F-48C4-89F6-E2F5D3FF2A35Q38237617-83D29ACA-756D-4714-9953-38AD9BC6CB96
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical evidence for the regression of liver fibrosis.
@en
Clinical evidence for the regression of liver fibrosis.
@nl
type
label
Clinical evidence for the regression of liver fibrosis.
@en
Clinical evidence for the regression of liver fibrosis.
@nl
prefLabel
Clinical evidence for the regression of liver fibrosis.
@en
Clinical evidence for the regression of liver fibrosis.
@nl
P1476
Clinical evidence for the regression of liver fibrosis.
@en
P2093
Derek A Mann
Elizabeth L Ellis
P304
P356
10.1016/J.JHEP.2011.09.024
P577
2012-01-13T00:00:00Z